Menstrual Blood Stem Cells in Severe Covid-19

Clinical trial NCT05019287 · COMPLETED

Trial details

NCT number: NCT05019287
Sponsor: Avicenna Research Institute
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Covid19 Cytokine Storm

Start date: 2021-04-17
Primary completion: 2021-05-21
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.